Golden
LSP BioVentures

LSP BioVentures

A Cambridge-based venture capital firm that invests in companies within the life science sector

LSP BioVentures is a venture capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, Lumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, Luxendo, Sequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits. 



Timeline

2006

Founded

Funded Companies

Company
Website
Industry
Location
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Joachim Rothe

Team Member



John de Koning

Team Member



Mark Wegter

Team Member



Martijn Kleijwegt

Team Member



René Kuijten

Team Member



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Aelin Therapeutics







arGEN-X







Eloxx







Imcyse, Lumeon







Immunic







Luxendo







Nouscom







Rainier Therapeutics







Sequana Medical







References